Gene · 116511
Papers1,411
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,411
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The role of renin-angiotensin system modulation in the pathophysiology of neuropsychiatric disorders. | Horm Behav | 2026 | 42826581 | PubTator, text mining | PubMed |
| Compound microbial intelligent membrane fermentation reshapes the virome and reduces various resistance genes in duck litter. | Front Microbiomes | 2026 | 42769134 | PubTator, text mining | PubMed |
| Cross talk between SARS-CoV-2 and the angiotensin system: clinical implications. | Am J Physiol Cell Physiol | 2026 | 42684673 | PubTator, text mining | PubMed |
| Epicardial adipose tissue as a metabolically active visceral fat depot: an emerging target in cardiovascular disease. | Front Cardiovasc Med | 2026 | 42581975 | PubTator, text mining | PubMed |
| ACE2/Angiotensin 1-7/Mas Receptor Axis in Thermogenic Adipose Tissue: Age-Related Implications for Pediatric Obesity. | Pediatr Int | 2026 | 42482457 | PubTator, text mining | PubMed |
| The balance between classical and alternative renin-angiotensin system in ARDS: a narrative review. | J Intensive Care | 2026 | 42135861 | PubTator, text mining | PubMed |
| Cryo-EM Structure of the Human Mas Receptor Reveals N-terminal Occlusion of the Orthosteric Ligand Binding Pocket. | J Mol Biol | 2026 | 42105974 | PubTator, text mining | PubMed |
| Integrated transcriptomic and single cell analysis combined with artificial neural network identifies a robust gene signature for early discrimination of MASL and MASH. | Front Immunol | 2026 | 42088521 | PubTator, text mining | PubMed |
| Disease-driven loss of inactive HSD17B13 isoforms enhances enzymatic output in MASH and counters protective rs72613567:TA variant. | JHEP Rep | 2026 | 41990578 | PubTator, text mining | PubMed |
| Activation of the protective arm of renin-angiotensin system enhances mitochondrial turnover improving respiration and decreasing integrated stress response in a human Complex III deficiency model. | bioRxiv | 2026 | 41929162 | PubTator, text mining | PubMed |
| Bifunctional Peptide Amphiphile Hydrogel Orchestrates Concerted Antioxidant and Anti-Inflammatory Actions to Counter Myocardial Ischemia/Reperfusion Injury. | Adv Healthc Mater | 2026 | 41906933 | PubTator, text mining | PubMed |
| Association of angiotensin converting enzyme type 2 serum level and gene polymorphisms with multiple sclerosis. | Sci Rep | 2026 | 41905970 | PubTator, text mining | PubMed |
| Angiotensin-(1-7) Alleviates Isoproterenol-Induced Cardiac Hypertrophy by Suppressing Autophagy and Apoptosis Through the Synergistic Action of Mas Receptor and Angiotensin II Type 2 Receptor. | Acta Physiol (Oxf) | 2026 | 41886752 | PubTator, text mining | PubMed |
| Disruption of Mitophagy-Related Gene Expression in Gestational Diabetes Mellitus: A Transcriptomic and Machine Learning Approach. | J Diabetes Res | 2026 | 41873208 | PubTator, text mining | PubMed |
| Mitochondrial dysfunction and programmed cell death in Alzheimer's disease: A retrospective bioinformatics study. | Medicine (Baltimore) | 2026 | 41861196 | PubTator, text mining | PubMed |
| Therapeutic Opportunities Targeting the ACE2/Ang-(1-7)/MasR Pathway in Cardiometabolic Disease. | Curr Hypertens Rep | 2026 | 41838282 | PubTator, text mining | PubMed |
| Angiotensin 1-7 Modulates the Dynamics and Activation of the Proto-Oncogene Mas Receptor. | J Mol Recognit | 2026 | 41833406 | PubTator, text mining | PubMed |
| Glucagon-Like Peptide-1 Receptor Agonists in Chronic Kidney Disease: Mechanisms and Clinical Perspectives. | Kidney Med | 2026 | 41808780 | PubTator, text mining | PubMed |
| The role of metabolic stress, xanthine oxidase, NOX2, and redox-related signalling in regulating ACE2 protein expression in exercising human skeletal muscle. | Free Radic Biol Med | 2026 | 41802614 | PubTator, text mining | PubMed |
| Prognostic impact of myelodysplasia-related gene mutations in ELN-2022 favorable-risk acute myeloid leukemia subtypes. | Ann Med | 2026 | 41797681 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/116511/papers